Tardyferon(Tardyferon 80 mg), 80 mg of iron(II) ions, prolonged-release tablets
Ferrous sulfate
Tardyferon and Tardyferon 80 mg are different trade names for the same drug.
The need for iron is increased in women during pregnancy, postpartum, breastfeeding, and in adolescents during growth. Iron deficiency or iron deficiency anemia can be prevented or treated with a medicine called Tardyferon.
In combination with iron and excipients, Fe ions are released slowly, which allows avoiding the sudden absorption of the entire iron dose into the blood serum.
This reduces the number of observed side effects and makes it easier for the patient to follow the recommendations. The slow release of the medicine allows iron ions to reach the final sections of the intestine, which, in addition to the duodenum, have the ability to absorb iron. The limitation of iron absorption to the upper segments of the intestine is caused by the iron saturation process. Like all iron-containing medicines, Tardyferon has no effect on erythropoiesis (red blood cell production) or anemia caused by factors other than iron deficiency.
Tardyferon is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women with insufficient dietary intake.
Tardyferon is indicated for use in children over 10 years of age and adults.
Before starting to take Tardyferon, you should discuss it with your doctor or pharmacist.
The toxic dose of iron is lower for children than for adults. It is not recommended to give Tardyferon to children under 10 years of age.
Iron deficiency supplementation should be, if possible, combined with treatment of the cause of the deficiency.
If the tablet gets into the airways, patients, especially the elderly and those with swallowing difficulties, may also be at risk of throat ulcers, esophageal ulcers, or bronchial ulcers. Bronchial necrosis (tissue death) or granuloma (inflammatory condition) can lead to bronchial stenosis (narrowing of the airways). In case of improper swallowing, you should immediately contact a doctor or the nearest emergency department for proper treatment.
In medical literature, in elderly patients with chronic kidney disease, diabetes (high blood sugar levels), and (or) hypertension (high blood pressure) treated with several medicines for these diseases and receiving iron supplementation due to accompanying anemia, gastrointestinal melanosis (discoloration of the gastrointestinal tract) has been described.
Due to the risk of oral ulcers and tooth discoloration, the tablets should not be sucked, chewed, or kept in the mouth, but swallowed whole, washed down with water. If it is not possible to follow these instructions or if there are difficulties with swallowing, you should contact a doctor.
Tardyferon can be used in children over 10 years of age.
You should not take Tardyferon unless your doctor decides to do so.
Some medicines cannot be taken at the same time, while others require special changes (e.g. time of administration).
You should avoid taking Tardyferon if you are taking iron-containing medicines for injection.
The following medicines may require a dose adjustment. You should not take Tardyferon within 2 hours of taking any of the following medicines:
If you are currently taking or have recently taken any other medicine that is available without a prescription, you should tell your doctor or pharmacist.
Consuming large amounts of coffee, tea, or red wine may reduce iron absorption.
It is not recommended to take this medicine at the same time as whole grain products (bran, legumes, oilseeds), certain proteins (eggs), or foods and drinks containing calcium (cheese, milk, etc.). You should keep a gap between taking iron salts and these foods (at least 2 hours).
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
Tardyferon can be used during pregnancy and breastfeeding.
It is unlikely that Tardyferon will affect your ability to drive or use machines.
This medicine should always be taken according to the doctor's or pharmacist's recommendations. In case of doubts, you should consult a doctor or pharmacist.
Tardyferon is indicated for children over 10 years of age and adults. The medicine is taken orally.
Treatment of iron deficiency anemia
Children over 10 years of age and adults: 1 to 2 tablets per day.
The duration of treatment should be long enough to correct anemia and replenish iron stores.
Treatment may last at least 3 to 6 months and can be extended if necessary in agreement with the doctor.
Preventive treatment
Cases of iron salt overdose have been reported, especially in children as a result of swallowing a large amount of the medicine.
Symptoms of overdose include signs of gastrointestinal irritation with accompanying abdominal pain, nausea, vomiting, diarrhea, symptoms of cardiovascular shock or metabolic acidosis (rapid or shallow breathing, rapid heartbeat, headache, confusion, drowsiness, fatigue, loss of appetite), and liver and kidney failure.
In case of taking too much medicine, you should immediately contact the emergency department for proper treatment.
If you miss a dose at the usual time, you should take it as soon as possible. However, if it is almost time for the next dose, you should not take the missed dose and take the next tablet as usual.
You should not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, you should consult a doctor or pharmacist.
Tardyferon should be taken for as long as your doctor recommends. If you stop the treatment too early, the disease may recur.
In case of any further doubts about taking this medicine, you should consult a doctor or pharmacist.
Like all medicines, Tardyferon can cause side effects, although not everybody gets them.
The following side effects may occur, listed in order of decreasing frequency:
Constipation, diarrhea, feeling of stomach fullness, abdominal pain, dark stool color, nausea.
Throat swelling (laryngeal edema), abnormal stools, discomfort and pain in the upper abdomen (indigestion), vomiting, acute gastritis, itching, red rash (erythematous rash).
Allergic reaction (hypersensitivity reaction), rash with itching (urticaria), pulmonary necrosis (tissue death)*, pulmonary granuloma (inflammatory condition)*, bronchial stenosis (narrowing of the airways)*, tooth discoloration**, oral ulcers**, changes in the esophagus*, discoloration of the gastrointestinal tract (gastrointestinal melanosis)*.
*Patients, especially the elderly and those with swallowing difficulties, may also be at risk of throat ulcers, esophageal ulcers, or bronchial ulcers if the tablet gets into the airways. Pulmonary necrosis (tissue death) or granuloma (inflammatory condition) can lead to bronchial stenosis (narrowing of the airways). In case of improper administration, you should immediately contact a doctor or the nearest emergency department for proper treatment.
**In case of improper administration, when tablets are chewed, sucked, or kept in the mouth.
In medical literature, in elderly patients with chronic kidney disease, diabetes (high blood sugar levels), and (or) hypertension (high blood pressure) treated with several medicines for these diseases and receiving iron supplementation due to accompanying anemia, gastrointestinal melanosis (discoloration of the gastrointestinal tract) has been described.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
There are no special precautions for the storage of the medicinal product.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
30 prolonged-release tablets in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Pierre Fabre Medicament
Les Cauquillous
Pierre Fabre Medicament Production
Site Progipharm, Gien, 45500, France
InPharm Sp. z o.o.
Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
Chełmżyńska 249
04-458 Warsaw
Lithuanian, export country marketing authorization number: LT/1/97/2578/001
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.